Eric Tseng
@tsengeric
Classical hematologist @UnityHealthTO (St. Michael's Hospital) with thrombosis focus. Proud girl daddy x 3. PD for @uoftmedicine Adult Heme Program
Bleeding & clotting = rock and hard place? Check out our new blog series "BLOOD & CLOTS" debuting now @WeAreCanadiEM canadiem.org/introduction-b…
Congrats to our amazing hematology graduates this year! Such a privilege to work with you all. @uoftmedicine

Our amazing DDD @sholzberg kicking off the inaugural U of T Hematology Community Building Day! Time to connect, connect, connect! @uoftmedicine

Stunning paper - neonatal thrombotic thrombocytopenic syndrome due to maternal anti-PF4 antibodies! nejm.org/doi/full/10.10…
Excellent 🇨🇦representation (including some honorary Canadians 🙃) at @ASH_hematology Run 🏃♀️ this morning. Biggest Type Eh! Running group ever!
Twelve projects led by St. Michael's Hospital have been awarded funding from the @CIHR_IRSC Project Grants. Congratulations to our researchers and their teams for receiving this outstanding recognition and support: bit.ly/2XIfr6y
Great turnout for the Thrombosis Canada 2024 Conference. Thanks to everyone who joined us today. #Thrombosis #WTDay24 #MedEd
Dr Amye Harrigan describing incidence of heavy menstrual bleeding in DOAC trials @ThrombosisCan

Do you struggle with whether to use anticoagulation for tumor thrombus? Hui et al. showed that patients with tumor thrombus have high risks of VTE, bleeding and mortality, and unfortunately the role of anticoagulation remains unclear. @TzufeiWang @MarcCarrier1 Read more at…
Amazing work by Dr @Maddie_Stephen!!
Here, @maddie_stephen and @sholzberg report on new findings on recombinant porcine factor VIII (rpFVIII) for acquired hemophilia A. 52% of patients had cross-reacting anti-human FVIII antibodies, reducing efficacy of rpFVIII in controlling bleeding. rpthjournal.org/article/S2475-…
Thank you @LisaHicksMD and @MarcCarrier1 for all your support, highlighting the risks of VTE and bleeding in patients with PCNSL. Hopefully this work can lead to improvements in care for this population.
In this #RPTH Review Article, @adamsuleman03 et al report their findings from a SR and meta-analysis on risk of VTE in 1ry CNS lymphoma ✅Pooled VTE rate= 11% ✅Fatal PE= 4% ✅High-quality data is lacking in this population @MarcCarrier1 @LisaHicksMD read rpthjournal.org/article/S2475-…
In clinic today, I saw a long-time patient in my practice who has had recurrent, significant medical illness She brought me close to tears when she said: "Whatever is on your mind these days, I want you to know that everything will be okay" Amazing when our patients heal us
Thinking about registering to attend the @ThrombosisCan conference? Below are some numbers to consider. Register today at bit.ly/3AeeK9b @TzufeiWang @MarcCarrier1 @LanaCastellucci @EddyLang1 @tsengeric
Ontario's iron deficiency guidelines are changing; the baseline of what's considered a normal amount of iron is increasing. Dr. Michelle @sholzberg, hematologist & scientist at St. Michael's Hospital, has been advocating for this change for years. cbc.ca/news/canada/to… 1/3
game-changing - a change in ferritin reference interval in Ontario!
In this #RPTH Review Article, @adamsuleman03 et al report their findings from a SR and meta-analysis on risk of VTE in 1ry CNS lymphoma ✅Pooled VTE rate= 11% ✅Fatal PE= 4% ✅High-quality data is lacking in this population @MarcCarrier1 @LisaHicksMD read rpthjournal.org/article/S2475-…
Incredibly excited to announce the official launch of our hematology education website - CBC Made Easy! Designed for all education levels, this website is a free tool to practice diagnosing various CBC abnormalities cbcmadeeasy.com
A patient with serious thrombotic episodes was found to have a monoclonal gammopathy of an anti–PF4 antibody. Myeloma therapy reduced the paraprotein level and prevented further thrombotic events. Read the full correspondence: nej.md/3SFWdsN
This is an important cohort study on OCP use after cessation of anticoagulation therapy for VTE
MEGA case-control study also confirms that OC use is safe during anticoagulant therapy for VTE but risk of recurrent events ⬆️ following anticoagulation cessation (provoked or unprovoked). doi.org/10.1016/j.jtha… @isth
Congrats to @sholzberg and Abi Vijenthira on this compelling population based cohort study regarding the risk of heme malignancies in patients with isolated thrombocytopenia - when should we consider a bone marrow?! onlinelibrary.wiley.com/doi/full/10.11…
One of my favourite events of the year - the OLYMPICS of Canadian thrombosis care! @ThrombosisCan

Updated guidance on reversal of direct oral anticoagulants, recent studies of antidotes, prothrombin complex concentrates, agents under investigation, FXI inhibitors & monitoring. @JerroldLevy @JRand083 @connors_md @DebSiegal Special 🙏 @MiddeldorpS jthjournal.org/article/S1538-…